Opportunity Overview
The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, is requesting quotations for Agilent/BioTek Instrument Maintenance, 75N98026Q01228, covering manufacturer-specific maintenance and calibration for temperature- and air-controlled automated microscopy systems used in high-throughput sickle cell disease drug-discovery research.
Deadline
Quotations are due September 21, 2026 at 5:00 PM Eastern Time.
Scope
The required firm-fixed-price service plan includes preventive maintenance and calibration, inspection, cleaning, adjustment, performance verification, applicable instrument updates, unlimited telephone support, repairs by qualified personnel, labor and travel, consumables, certified parts, and one preventive-maintenance visit per instrument each year.
Competition and Evaluation
NIH intends a sole-source purchase order to Agilent Technologies Inc. because the Government identified Agilent as the only source capable of providing the full combination of manufacturer-specific procedures, proprietary diagnostics and software tools, certified engineers, certified parts, calibration protocols, consumables, updates, and service guarantee. However, all responsible sources may submit a timely quotation demonstrating complete compliance with the RFQ and requirements document. Award will be made to a responsible organization whose quotation satisfies the Government’s requirements at a fair and reasonable price.
Submission
Written quotations must follow the RFQ response instructions and identify the offered services, manufacturer, service plan or contract information, performance period, pricing, service schedule, personnel qualifications, availability of manufacturer-certified engineers and parts, technical-support capabilities, and sufficient technical information to demonstrate complete compliance. The solicitation number must be referenced on all correspondence.
Funding / Contract Value
No fixed maximum contract value is stated in the public notice.
Qualification Guidance
This requirement is most relevant to Agilent or another source able to document equivalent manufacturer-authorized maintenance and calibration capability, certified personnel and parts, proprietary diagnostic access, and full compliance with the RFQ. No Dr. Miltie capability should be assumed without documentary evidence of these qualifications.